Browse by Journal Title

Article

The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.
Golubnitschaja, O., Polivka, J., Potuznik, P., Pesta, M., Stetkarova, I., Mazurakova, A., Lackova, L., Kubatka, P., Kropp, M., Thumann, G., Erb, C., Fröhlich, H., Wang, W., Baban, B., Kapalla, M., Shapira, N., Richter, K., Karabatsiakis, A., Smokovski, I., Schmeel, L.C., Gkika, E., Paul, F., Parini, P. and Polivka, J.
EPMA Journal 15 (1): 1-23. March 2024

Caution, "normal" BMI: health risks associated with potentially masked individual underweight - EPMA position paper 2021.
Golubnitschaja, O., Liskova, A., Koklesova, L., Samec, M., Biringer, K., Büsselberg, D., Podbielska, H., Kunin, A.A., Evsevyeva, M.E., Shapira, N., Paul, F., Erb, C., Dietrich, D.E., Felbel, D., Karabatsiakis, A., Bubnov, R., Polivka, J., Polivka, J.J., Birkenbihl, C., Fröhlich, H., Hofmann-Apitius, M. and Kubatka, P.
EPMA Journal 12 (3): 243-264. September 2021

Cultural bias in motor function patterns: potential relevance for predictive, preventive, and personalized medicine.
Otte, K., Ellermeyer, T., Suzuki, M., Röhling, H.M., Kuroiwa, R., Cooper, G., Mansow-Model, S., Mori, M., Zimmermann, H., Brandt, A.U., Paul, F., Hirano, S., Kuwabara, S. and Schmitz-Hübsch, T.
EPMA Journal 12 (1): 91-101. March 2021

Review

Suggestions for improving the design of clinical trials in multiple sclerosis - results of a systematic analysis of completed phase III trials.
Gehr, S., Kaiser, T., Kreutz, R., Ludwig, W.D. and Paul, F.
EPMA Journal 10 (4): 425-436. December 2019

Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies.
Borisow, N., Hellwig, K. and Paul, F.
EPMA Journal 9 (3): 249-256. September 2018

Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy.
Oertel, F.C., Zimmermann, H., Paul, F. and Brandt, A.U.
EPMA Journal 9 (1): 21-33. March 2018

Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases.
Koduah, P., Paul, F. and Dörr, J.M.
EPMA Journal 8 (4): 313-325. December 2017

Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system.
Kuchling, J., Brandt, A.U., Paul, F. and Scheel, M.
EPMA Journal 8 (3): 279-294. September 2017

The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue.
Veauthier, C., Hasselmann, H., Gold, S.M. and Paul, F.
EPMA Journal 7 : 25. 24 November 2016

Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management.
Sinnecker, T., Kuchling, J., Dusek, P., Dörr, J., Niendorf, T., Paul, F. and Wuerfel, J.
EPMA Journal 6 (1): 16. 27 August 2015

Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases.
Mähler, A., Mandel, S., Lorenz, M., Ruegg, U., Wanker, E.E., Boschmann, M. and Paul, F.
EPMA Journal 4 (1): 5. 18 February 2013

Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
Dörr, J., Döring, A. and Paul, F.
EPMA Journal 4 : 4. 29 January 2013

Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy.
Borisow, N., Doering, A., Pfueller, C.F., Paul, F., Doerr, J. and Hellwig, K.
EPMA Journal 3 (1): 9. 22 June 2012

Exercise in multiple sclerosis - an integral component of disease management.
Doering, A., Pfueller, C.F., Paul, F. and Doerr, J.
EPMA Journal 3 : 2. 24 December 2011

The German healthcare system.
Doering, A. and Paul, F.
EPMA Journal 1 (4): 535-547. December 2010